Materia Medica Holdings Ltd. Sustainability Profile
Materia Medica Holdings Ltd., a prominent player in the pharmaceutical industry, is headquartered in Russia (RU) and operates extensively across various regions. Founded in 1999, the company has established itself as a leader in the development and production of homeopathic medicines and innovative healthcare solutions. With a diverse portfolio that includes unique homeopathic remedies and over-the-counter products, Materia Medica stands out for its commitment to quality and efficacy. The company has achieved significant milestones, including numerous awards for its contributions to the field of homeopathy. Recognised for its market position, Materia Medica continues to expand its reach, providing effective healthcare solutions that cater to the evolving needs of patients and healthcare professionals alike.
DitchCarbon Score
How does Materia Medica Holdings Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Materia Medica Holdings Ltd.'s score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Materia Medica Holdings Ltd.'s reported carbon emissions
Materia Medica Holdings Ltd., headquartered in Russia, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and climate commitments suggests that Materia Medica Holdings Ltd. may not have established a formal framework for addressing its carbon footprint or engaging in sustainability initiatives. As the industry increasingly prioritises climate action, the absence of such commitments may impact the company's reputation and alignment with global sustainability trends.
How Carbon Intensive is Materia Medica Holdings Ltd.'s Industry?
How Carbon Intensive is Materia Medica Holdings Ltd.'s Location?
Materia Medica Holdings Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Materia Medica Holdings Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
